durapatite has been researched along with methotrexate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bond, AN; Harris, G; Wickramasinghe, SN | 1 |
| Dai, CF; Li, SP; Li, XD | 1 |
| Chandran, VG; Kowshik, M; Naik, K; Rajashekaran, R; Waigaonkar, S | 1 |
| Chu, W; Cui, S; Huang, Y; Liao, Y; Yan, M; Yang, C; Zhang, X; Zhao, C | 1 |
| Meshkini, A; Oveisi, H | 1 |
| Liu, S; Meng, X; Sun, H; Wan, Y; Zeng, X; Zhao, L; Zuo, G | 1 |
| Jayakrishnan, A; Kumar, TSS; Prasad, SR | 1 |
| Bouziotis, P; Datseris, IE; Furenlid, LR; Kastis, GA; Papachristou, M; Stavrou, PZ; Xanthopoulos, S | 1 |
| Ahmad, FJ; Kumar, V; Leekha, A; Pandey, S; Rai, N; Talegaonkar, S; Verma, AK | 1 |
| Ahmad, FJ; Mahtab, A; Mittal, D; Neupane, YR; Pandey, S; Rai, N; Sandal, N; Talegaonkar, S; Verma, AK | 1 |
10 other study(ies) available for durapatite and methotrexate
| Article | Year |
|---|---|
DNA chain elongation rates in marrow cells from vitamin B12-deficient patients and methotrexate-treated mice.
Topics: Anemia, Megaloblastic; Animals; Bone Marrow; Chromatography; DNA; Durapatite; Female; Humans; Hydroxyapatites; Hydroxyurea; Lymphocyte Activation; Male; Methotrexate; Mice; Mice, Inbred BALB C; Vitamin B 12 Deficiency | 1982 |
Synthesis of nanostructured methotrexate/hydroxyapatite: Morphology control, growth mechanism, and bioassay explore.
Topics: Biological Assay; Calorimetry, Differential Scanning; Durapatite; Methotrexate; Microscopy, Electron, Transmission; Nanostructures; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; X-Ray Diffraction | 2015 |
Mechanical properties, biological behaviour and drug release capability of nano TiO2-HAp-Alginate composite scaffolds for potential application as bone implant material.
Topics: Alginates; Bone Substitutes; Cell Adhesion; Cell Line; Compressive Strength; Diffusion; Drug Implants; Durapatite; Feasibility Studies; Glucuronic Acid; Hardness; Hexuronic Acids; Humans; Materials Testing; Methotrexate; Nanocapsules; Nanocomposites; Osteoblasts; Particle Size; Prostheses and Implants; Titanium | 2016 |
Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.
Topics: Alendronate; Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Calcium Phosphates; Cell Line; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Durapatite; Female; Humans; Methotrexate; Mice; Nanoparticles; Photoelectron Spectroscopy; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2017 |
Methotrexate-F127 conjugated mesoporous zinc hydroxyapatite as an efficient drug delivery system for overcoming chemotherapy resistance in osteosarcoma cells.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Drug Delivery Systems; Durapatite; Humans; Hydrogen-Ion Concentration; Methotrexate; Osteosarcoma; Polyethylenes; Polypropylenes; Zinc | 2017 |
Morphology effect of nano-hydroxyapatite as a drug carrier of methotrexate.
Topics: Cell Proliferation; Cell Survival; Drug Carriers; Drug Liberation; Durapatite; HeLa Cells; Humans; Materials Testing; Methotrexate; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |
Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cattle; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Methotrexate; Nanoparticles; Osteosarcoma; Polyvinyl Alcohol; Serum Albumin, Bovine | 2018 |
Radiolabeled methotrexate as a diagnostic agent of inflammatory target sites: A proof-of-concept study.
Topics: Animals; Drug Stability; Durapatite; Humans; Inflammation; Isotope Labeling; Methotrexate; Mice; Molecular Imaging; Organotechnetium Compounds; Protein Binding; Tissue Distribution | 2018 |
Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Crotonates; Drug Carriers; Drug Combinations; Drug Compounding; Drug Liberation; Drug Stability; Durapatite; Female; Hydrogen-Ion Concentration; Hydroxybutyrates; Kinetics; Methotrexate; Nanoparticles; Nitriles; Oxidative Stress; Particle Size; Rats; Rats, Wistar; Tissue Distribution; Toluidines | 2018 |
Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Crotonates; Cytokines; Drug Carriers; Drug Evaluation, Preclinical; Drug Liberation; Durapatite; Hyaluronic Acid; Hydroxybutyrates; Liver; Methotrexate; Mice; Nanoparticles; Nitriles; Rats; Rats, Wistar; RAW 264.7 Cells; Spectroscopy, Fourier Transform Infrared; Tissue Distribution; Toluidines | 2021 |